2.5/1000 4222 (Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg)

Generic Name: metformin/saxagliptin

This pill with imprint "2.5/1000 4222" is Yellow, Capsule-shape and has been identified as Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg. It is manufactured by Bristol-Myers Squibb.

Kombiglyze XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Kombiglyze XR

Generic Name:

metformin/saxagliptin

Imprint:

2.5/1000 4222

Strength:

metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg

Color:

Yellow

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antidiabetic combinations

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Bristol-Myers Squibb

National Drug Code (NDC):

00003-4222

Inactive Ingredients:

carboxymethylcellulose sodium
hypromellose 2208 (15000 mPa.s)
magnesium stearate

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
00310-6125	AstraZeneca Pharmaceuticals LP

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.